SHL Medical Opens $220M Autoinjector Facility in SC

Key Highlights:

  • SHL Medical inaugurates a $220M facility in North Charleston, SC

  • Over 300 local jobs created, supporting economic growth

  • Strategic expansion boosts global autoinjector production capacity

  • Fully automated 360,000 ft² site with cutting-edge technologies

  • Supports growing demand in cardiometabolic and other therapy areas

Source: PR Newswire

Notable Quotes:

"US-based production is a major step forward in our global expansion and reinforces our position as the leader in providing end-to-end drug delivery solutions."

Ulrich Faessler, CEO & Chairman at SHL Medical

"The most trusted autoinjector brand is now made in the USA. We are proud to be contributing to the growth of the local economy and becoming a key player in the area while contributing to our sustainability goals."

Kimberlee Steele, Managing Director North America at SHL Medical

Why This Matters:

SHL Medical’s new facility in South Carolina marks a major milestone in the global biopharma supply chain, enhancing access to life-saving autoinjector technologies. The investment not only reinforces the company’s leadership in drug delivery systems but also strengthens the U.S. manufacturing ecosystem with sustainable practices and robust job creation. As chronic conditions requiring self-injection therapies rise, this expansion ensures SHL Medical remains at the forefront of healthcare innovation and delivery.